Rigel Pharmaceuticals shares rise on RBC Capital Markets analyst upgradeRigel Pharmaceuticals Inc. rose after an RBC Capital Markets analyst recommended buying shares of the drug developer based on his expectations the company will announce news of a partnership for a key drug candidate. Rigel's shares rose 40 cents, or ...